Fujita Health University · Cancer Research Center

Research keywordscancer genomics・epigenomic classification・drug sensitivity testing・patient-derived cancer models・treatment resistance・precision oncology・autophagy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Feasibility of long-read nanopore sequencing for methylation-based classification of posterior fossa ependymomas.2026 · Brain tumor pathology
• Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective series.2026 · Clinical neurology and neurosurgery
• Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development2026 · Cells
• Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy.2026 · Cancer science

• 口腔癌のエクソソームとCD47スプライシングアイソフォームによる免疫逃避の解明2025 · 科学研究費助成事業
• メチオニン代謝を基盤としたがん治療抵抗性機構の解明と新規治療標的の同定2021 · 科学研究費助成事業
• がん関連線維芽細胞誘導分子機構の解明とその阻害に基づく腫瘍微小環境制御2020 · 科学研究費助成事業
• 癌細胞シグナル活性化因子14-3-3ζを標的とした新規膵臓癌治療薬の開発2019 · 科学研究費助成事業

• Official profile